Determining the Role of Bub1 in T Antigen Mediated Transformation
Determining the Role of Bub1 in T Antigen Mediated Transformation
批准号:
6989674
负责人:
THOMAS M ROBERTS
金额:
$26.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-27 至 2009-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have detected a functional interaction between SV40 large T antigen and the mitotic regulator Bub 1. The protein kinase Bub1, a member of the family of checkpoint proteins that monitor the assembly of the mitotic spindle, has been found to be mutated in certain human cancers characterized by aneuploidy. Notably, T antigen can also cause genomic instability by inducing chromosomal aberrations and aneuploidy. T antigen co-immunoprecipitates with endogenous Bub1, as well as with Bub3, another component of the checkpoint complex at the kinetochore. While we have come to think of T antigen as an inactivator of its target proteins
as is the case with p53 and pRb, T actually enhances Bub1 kinase activity. Bub1 phosphorylates p53 on ser37, previously identified as a site of phosphorylation by DNA-PK. Genetic analysis demonstrates that interaction of T antigen with Bub1 is not required for immortalization but appears to be necessary for T antigen to deregulate the spindle assembly checkpoint and transform. This interaction with Bub1 suggests a novel role for T antigen, which may provide new insight into its ability to regulate p53, cause chromosome aberrations, and transform. We propose to study the interaction in detail. It is our intent to determine:
(1) What are the the mechanistic consequences of Bub1 mediated phosphorylation of p53? (2) Does T antigen direct Bub1 toward other substrates in addition to p53? And (3) Is T antigen's interaction with Bub1 required for T antigen to destabilize the chromosomes in its target cells?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:9816457
-
项目类别:
-
资助金额:$92.54万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:10238853
-
项目类别:
-
资助金额:$104.98万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:9978752
-
项目类别:
-
资助金额:$104.98万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:10705059
-
项目类别:
-
资助金额:$102.88万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:10468110
-
项目类别:
-
资助金额:$102.88万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
PROJECT 2: Oncogenic Transformation via the PP2A/YAP/Hippo pathway
-
批准号:10227783
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2017
-
负责人:THOMAS M ROBERTS
-
依托单位:
PROJECT 2: Oncogenic Transformation via the PP2A/YAP/Hippo pathway
-
批准号:9981671
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2017
-
负责人:THOMAS M ROBERTS
-
依托单位:
Targeting the PI3K Signaling Axis
-
批准号:8588487
-
项目类别:
-
资助金额:$40.47万
-
财政年份:2013
-
负责人:THOMAS M ROBERTS
-
依托单位:
Overcoming Resistance to Standard HER2-Directed Therapies for Breast Cancer
-
批准号:8607754
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2013
-
负责人:THOMAS M ROBERTS
-
依托单位:
The Role of Bub1 in SV40 Large T Mediated Transformation
-
批准号:8233029
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2011
-
负责人:THOMAS M ROBERTS
-
依托单位:
Amoeboid Motility--A Cellular and Genetic Approach
-
批准号:7892239
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2009
-
负责人:THOMAS M ROBERTS
-
依托单位:
Targeting PTEN Null Tumors via Inhibition of the p110beta Isoform of PI3 Kinase
-
批准号:7852681
-
项目类别:
-
资助金额:$130.29万
-
财政年份:2009
-
负责人:THOMAS M ROBERTS
-
依托单位:
The Role of Bub1 in SV40 Large T Mediated Transformation
-
批准号:7647584
-
项目类别:
-
资助金额:$40.17万
-
财政年份:2009
-
负责人:THOMAS M ROBERTS
-
依托单位:
Targeting PTEN Null Tumors via Inhibition of the p110beta Isoform of PI3 Kinase
-
批准号:7942793
-
项目类别:
-
资助金额:$135.08万
-
财政年份:2009
-
负责人:THOMAS M ROBERTS
-
依托单位:
Project 2 - Effects of Herb Fractions on Cell Function/Regulation:
-
批准号:7048909
-
项目类别:
-
资助金额:$5.54万
-
财政年份:2005
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:7227166
-
项目类别:
-
资助金额:$68.63万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:7413945
-
项目类别:
-
资助金额:$69.15万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:6826346
-
项目类别:
-
资助金额:$66.45万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:7076835
-
项目类别:
-
资助金额:$68.79万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:6922876
-
项目类别:
-
资助金额:$68.48万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
海外基金